关注
Pushpinder Kaur
Pushpinder Kaur
在 med.usc.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India
RC Sobti, S Kaur, P Kaur, J Singh, I Gupta, V Jain, A Nakahara
Cancer genetics and cytogenetics 166 (2), 117-123, 2006
1092006
DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection
P Kaur, A Paliwal, D Durantel, P Hainaut, JY Scoazec, F Zoulim, I Chemin, ...
The Journal of infectious diseases 202 (5), 700-704, 2010
892010
Contrasting Impact of DNA Repair Gene XRCC1 Polymorphisms Arg399Gln And Arg194Trp on The Risk of Lung Cancer in the North-Indian Population
SS Pachouri, RC Sobti, P Kaur, J Singh
DNA and cell biology 26 (3), 186-191, 2007
642007
CYP17, SRD5A2, CYP1B1, and CYP2D6 Gene Polymorphisms with Prostate Cancer Risk in North Indian Population
RC Sobti, K Onsory, AI Al-Badran, P Kaur, M Watanabe, A Krishan, ...
DNA and cell biology 25 (5), 287-294, 2006
632006
Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma
P Kaur, S Mani, MP Cros, JY Scoazec, I Chemin, P Hainaut, Z Herceg
Tumor Biology 33, 325-336, 2012
602012
XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population
RC Sobti, J Singh, P Kaur, SS Pachouri, EA Siddiqui, HS Bindra
Cancer genetics and cytogenetics 175 (2), 91-97, 2007
562007
RNA-Seq of circulating tumor cells in stage II–III breast cancer
JE Lang, A Ring, T Porras, P Kaur, VA Forte, N Mineyev, D Tripathy, ...
Annals of surgical oncology 25, 2261-2270, 2018
502018
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer
A Ring, P Kaur, JE Lang
BMC cancer 20, 1-14, 2020
482020
Role of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian population
RC Sobti, L Gupta, SK Singh, A Seth, P Kaur, H Thakur
Cancer genetics and cytogenetics 185 (2), 78-85, 2008
452008
Bovine babesiosis due to babesia bigemina haematobiochemical and therapeutic studies
GS Aulakh, LD Singla, P Kaur, A Alka
The Indian journal of animal sciences 75 (6), 2005
412005
Challenges in using liquid biopsies for gene expression profiling
TB Porras, P Kaur, A Ring, N Schechter, JE Lang
Oncotarget 9 (6), 7036, 2018
402018
Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population
K Onsory, RC Sobti, AI Al-Badran, M Watanabe, T Shiraishi, A Krishan, ...
Molecular and cellular biochemistry 314, 25-35, 2008
392008
Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer
RC Sobti, P Kaur, S Kaur, AK Janmeja, SK Jindal, J Kishan, S Raimondi
Biomarkers 13 (3), 282-295, 2008
392008
Attenuation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine
A Sharma, P Kaur, V Kumar, KD Gill
Cellular and molecular biology 53 (1), 48-55, 2007
382007
Impact of polymorphism in sulfotransferase gene on the risk of lung cancer
SS Pachouri, RC Sobti, P Kaur, J Singh, SK Gupta
Cancer genetics and cytogenetics 171 (1), 39-43, 2006
382006
Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population
RC Sobti, P Kaur, S Kaur, J Singh, AK Janmeja, SK Jindal, J Kishan, ...
Cancer genetics and cytogenetics 170 (2), 108-114, 2006
382006
Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population
K Satinder, SR Chander, K Pushpinder, G Indu, J Veena
Molecular and cellular biochemistry 315, 151-157, 2008
372008
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer
P Kaur, TB Porras, A Ring, JD Carpten, JE Lang
Scientific reports 9 (1), 1482, 2019
312019
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System
EN Cohen, G Jayachandran, RG Moore, M Cristofanilli, JE Lang, ...
Cancers 14 (21), 5238, 2022
302022
The epigenome as a potential mediator of cancer and disease prevention in prenatal development
P Kaur, LE Shorey, E Ho, RH Dashwood, DE Williams
Nutrition reviews 71 (7), 441-457, 2013
302013
系统目前无法执行此操作,请稍后再试。
文章 1–20